474 filings
Page 10 of 24
8-K
MYMD
MyMD Pharmaceuticals Inc
11 Sep 20
Departure of Directors or Certain Officers
5:16pm
8-A12B
MYMD
MyMD Pharmaceuticals Inc
9 Sep 20
Registration of securities on exchange
4:55pm
8-K
MYMD
MyMD Pharmaceuticals Inc
9 Sep 20
Entry into a Material Definitive Agreement
4:50pm
424B3
MYMD
MyMD Pharmaceuticals Inc
8 Sep 20
Prospectus supplement
5:30pm
8-K/A
MYMD
MyMD Pharmaceuticals Inc
1 Sep 20
Departure of Directors or Certain Officers
4:34pm
3
Stuart M Benson
31 Aug 20
Akers Biosciences / Stuart M Benson ownership change
1:13pm
8-K
MYMD
MyMD Pharmaceuticals Inc
28 Aug 20
Departure of Directors or Certain Officers
5:04pm
8-K
MYMD
MyMD Pharmaceuticals Inc
27 Aug 20
Akers Biosciences and Premas Biotech Announce SARS CoV-2 Positive Proof of Concept Results
9:05am
EFFECT
MYMD
MyMD Pharmaceuticals Inc
26 Aug 20
Notice of effectiveness
12:15am
CORRESP
MYMD
MyMD Pharmaceuticals Inc
24 Aug 20
Correspondence with SEC
12:00am
UPLOAD
MYMD
MyMD Pharmaceuticals Inc
21 Aug 20
Letter from SEC
12:00am
S-3
MYMD
MyMD Pharmaceuticals Inc
Shelf registration
18 Aug 20
7:19am
10-Q
2020 Q2
MYMD
MyMD Pharmaceuticals Inc
Quarterly report
14 Aug 20
4:11pm
8-K
MYMD
MyMD Pharmaceuticals Inc
13 Aug 20
Entry into a Material Definitive Agreement
8:45am
424B5
MYMD
MyMD Pharmaceuticals Inc
13 Aug 20
Prospectus supplement for primary offering
8:40am
D
MYMD
MyMD Pharmaceuticals Inc
11 Aug 20
$0 in equity, 1 investor
3:49pm
UPLOAD
MYMD
MyMD Pharmaceuticals Inc
10 Aug 20
Letter from SEC
12:00am
8-K
MYMD
MyMD Pharmaceuticals Inc
10 Aug 20
Entry into a Material Definitive Agreement
12:00am
DEF 14A
MYMD
MyMD Pharmaceuticals Inc
Definitive proxy
29 Jul 20
9:46am
8-K
MYMD
MyMD Pharmaceuticals Inc
27 Jul 20
Departure of Directors or Certain Officers
12:00am